找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊Iranian Journal of Basic Medical Sciences 2024/2025影响因子:2.117 (IRAN J BASIC MED SCI) (2008-3866). (PHARMACOLOGY &  ...234
Total Citations:4268; 2023 JIF:2.117; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.562; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.5; Immediacy Index-dealt:0.577; 2023 JCI:0.53; JCI Rank: 225/354 ; Total Articles:168; JCI Quartile:Q3; JCI Percentile:36.58; Eigenfactor:0.003; Normalized Eigenfactor:0.678; Article Influence Score:0.383; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:180; % of Articles in Citable items:0.9333; Cited Half-Life:5.2; Citing Half-Life:7.3; % of OA Gold:0; Publisher name:WALTER DE GRUYTER GMBH; Publisher address:GENTHINER STRASSE 13, BERLIN, GERMAN
投票 SCIE期刊Pharmacology Research & Perspectives 2024/2025影响因子:2.931 (PHARMACOL RES PERSPE) (2052-1707). (PHARMACOLOGY & PHAR  ...234
Total Citations:2488; 2023 JIF:2.931; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:2.981; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.6; Immediacy Index-dealt:0.659; 2023 JCI:0.73; JCI Rank: 154/354 ; Total Articles:94; JCI Quartile:Q2; JCI Percentile:56.64; Eigenfactor:0.004; Normalized Eigenfactor:0.787; Article Influence Score:0.72; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:104; % of Articles in Citable items:0.9038; Cited Half-Life:3.7; Citing Half-Life:8.5; % of OA Gold:0.6787; Publisher name:MICROBIOLOGY SOC; Publisher address:14-16 MEREDITH ST, LONDON, England, EC1
投票 SCIE期刊BIOLOGICALS 2024/2025影响因子:1.536 (BIOLOGICALS) (1045-1056). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Inde  ...234
Total Citations:1680; 2023 JIF:1.536; JIFRank: 265/354 ; Rank-JIF: 265; Number-of-JIF:354; 5 Year JIF:1.627; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.3; Immediacy Index:0.3; Immediacy Index-dealt:0.392; 2023 JCI:0.41; JCI Rank: 267/354 ; Total Articles:49; JCI Quartile:Q4; JCI Percentile:20.4; Eigenfactor:0.001; Normalized Eigenfactor:0.18; Article Influence Score:0.353; JIF Percentile:17; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:51; % of Articles in Citable items:0.9608; Cited Half-Life:9.1; Citing Half-Life:8.4; % of OA Gold:0.4252; Publisher name:ELSEVIER; Publisher address:RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX;
投票 SCIE期刊Pharmaceutics 2024/2025影响因子:4.962 (PHARMACEUTICS) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index  ...234
Total Citations:45421; 2023 JIF:4.962; JIFRank: 45/354 ; Rank-JIF: 45; Number-of-JIF:354; 5 Year JIF:5.567; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.3; Immediacy Index:1.6; Immediacy Index-dealt:1.615; 2023 JCI:1.3; JCI Rank: 42/354 ; Total Articles:1926; JCI Quartile:Q1; JCI Percentile:88.28; Eigenfactor:0.047; Normalized Eigenfactor:10.34; Article Influence Score:0.797; JIF Percentile:87.4; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:2749; % of Articles in Citable items:0.7006; Cited Half-Life:2.5; Citing Half-Life:6.4; % of OA Gold:0.9964; Publisher name:BRISTOL UNIV PRESS & POLICY PRESS; Publisher address:1-9 OLD PARK HILL, UN
投票 SCIE期刊ANNALS OF PHARMACOTHERAPY 2024/2025影响因子:2.377 (ANN PHARMACOTHER) (1060-0280). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sc  ...234
Total Citations:7086; 2023 JIF:2.377; JIFRank: 199/354 ; Rank-JIF: 199; Number-of-JIF:354; 5 Year JIF:2.608; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.2; Immediacy Index:0.4; Immediacy Index-dealt:0.494; 2023 JCI:0.5; JCI Rank: 236/354 ; Total Articles:71; JCI Quartile:Q3; JCI Percentile:33.47; Eigenfactor:0.005; Normalized Eigenfactor:1.095; Article Influence Score:0.793; JIF Percentile:43.9; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:131; % of Articles in Citable items:0.542; Cited Half-Life:11.2; Citing Half-Life:6.1; % of OA Gold:0.0377; Publisher name:UNIV CHICAGO PRESS; Publisher address:1427 E 60TH ST, CHICAGO, USA, IL, 606
投票 SCIE期刊Drug Delivery and Translational Research 2024/2025影响因子:5.728 (DRUG DELIV TRANSL RE) (2190-393X). (PHARMACOLOGY &  ...234
Total Citations:5943; 2023 JIF:5.728; JIFRank: 30/354 ; Rank-JIF: 30; Number-of-JIF:354; 5 Year JIF:5.527; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.6; Immediacy Index:0.8; Immediacy Index-dealt:0.861; 2023 JCI:1.34; JCI Rank: 38/354 ; Total Articles:176; JCI Quartile:Q1; JCI Percentile:89.41; Eigenfactor:0.006; Normalized Eigenfactor:1.215; Article Influence Score:0.804; JIF Percentile:91.7; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:203; % of Articles in Citable items:0.867; Cited Half-Life:3.5; Citing Half-Life:6; % of OA Gold:0.2738; Publisher name:JOHNS HOPKINS UNIV PRESS; Publisher address:JOURNALS PUBLISHING DIVISION, 2715
投票 SCIE期刊CURRENT OPINION IN PHARMACOLOGY 2024/2025影响因子:4.162 (CURR OPIN PHARMACOL) (1471-4892). (PHARMACOLOGY & PHARMACY)(  ...234
Total Citations:6924; 2023 JIF:4.162; JIFRank: 82/354 ; Rank-JIF: 82; Number-of-JIF:354; 5 Year JIF:4.127; 5 Year JIF Quartile:Q2; JIF Without Self Cites:4; Immediacy Index:1.2; Immediacy Index-dealt:1.286; 2023 JCI:1.28; JCI Rank: 44/354 ; Total Articles:28; JCI Quartile:Q1; JCI Percentile:87.71; Eigenfactor:0.005; Normalized Eigenfactor:1.047; Article Influence Score:1.058; JIF Percentile:77; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:31; % of Articles in Citable items:0.9032; Cited Half-Life:8.7; Citing Half-Life:6.3; % of OA Gold:0.3597; Publisher name:ELSEVIER SCI LTD; Publisher address:125 London Wall, London, England, EC2Y 5AS;
投票 SCIE期刊EXPERT OPINION ON THERAPEUTIC TARGETS 2024/2025影响因子:4.632 (EXPERT OPIN THER TAR) (1472-8222). (PHARMACOLOGY & PHA  ...234
Total Citations:6046; 2023 JIF:4.632; JIFRank: 57/354 ; Rank-JIF: 57; Number-of-JIF:354; 5 Year JIF:6.323; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.5; Immediacy Index:0.6; Immediacy Index-dealt:0.699; 2023 JCI:0.8; JCI Rank: 125/354 ; Total Articles:22; JCI Quartile:Q2; JCI Percentile:64.83; Eigenfactor:0.005; Normalized Eigenfactor:1.02; Article Influence Score:1.555; JIF Percentile:84; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:93; % of Articles in Citable items:0.2366; Cited Half-Life:7.6; Citing Half-Life:6.9; % of OA Gold:0.1379; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊Biomolecules & Therapeutics 2024/2025影响因子:3.133 (BIOMOL THER) (1976-9148). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scien  ...234
Total Citations:2620; 2023 JIF:3.133; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.595; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.8; Immediacy Index:0.8; Immediacy Index-dealt:0.898; 2023 JCI:0.72; JCI Rank: 160/354 ; Total Articles:50; JCI Quartile:Q2; JCI Percentile:54.94; Eigenfactor:0.002; Normalized Eigenfactor:0.436; Article Influence Score:0.673; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:63; % of Articles in Citable items:0.7937; Cited Half-Life:6; Citing Half-Life:8.3; % of OA Gold:0.8186; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE,
投票 SCIE期刊Journal of Ethnobiology and Ethnomedicine 2024/2025影响因子:2.971 (J ETHNOBIOL ETHNOMED) (NULL). (PHARMACOLOGY & PHAR  ...234
Total Citations:3857; 2023 JIF:2.971; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:3.649; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.7; Immediacy Index-dealt:0.772; 2023 JCI:0.89; JCI Rank: 103/354 ; Total Articles:55; JCI Quartile:Q2; JCI Percentile:71.05; Eigenfactor:0.002; Normalized Eigenfactor:0.387; Article Influence Score:0.589; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:63; % of Articles in Citable items:0.873; Cited Half-Life:8.3; Citing Half-Life:9.5; % of OA Gold:0.9951; Publisher name:UNIV PENNSYLVANIA PRESS; Publisher address:JOURNALS DIVISION, 3905 SPRUCE ST
投票 SCIE期刊JOURNAL OF PHARMACY AND PHARMACOLOGY 2024/2025影响因子:2.842 (J PHARM PHARMACOL) (0022-3573). (PHARMACOLOGY & PHARMAC  ...234
Total Citations:11018; 2023 JIF:2.842; JIFRank: 158/354 ; Rank-JIF: 158; Number-of-JIF:354; 5 Year JIF:3.847; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.8; Immediacy Index:0.5; Immediacy Index-dealt:0.534; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:101; JCI Quartile:Q2; JCI Percentile:61.72; Eigenfactor:0.004; Normalized Eigenfactor:0.832; Article Influence Score:0.589; JIF Percentile:55.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:122; % of Articles in Citable items:0.8279; Cited Half-Life:11.6; Citing Half-Life:7.6; % of OA Gold:0.0945; Publisher name:AL-FARABI KAZAKH NATL UNIV; Publisher address:INST APPL MATH, BAKU STAT
投票 SCIE期刊TRENDS IN PHARMACOLOGICAL SCIENCES 2024/2025影响因子:13.932 (TRENDS PHARMACOL SCI) (0165-6147). (PHARMACOLOGY & PHARM  ...234
Total Citations:14644; 2023 JIF:13.932; JIFRank: 6/354 ; Rank-JIF: 6; Number-of-JIF:354; 5 Year JIF:14.328; 5 Year JIF Quartile:Q1; JIF Without Self Cites:13.8; Immediacy Index:3.9; Immediacy Index-dealt:3.988; 2023 JCI:1.99; JCI Rank: 15/354 ; Total Articles:2; JCI Quartile:Q1; JCI Percentile:95.9; Eigenfactor:0.011; Normalized Eigenfactor:2.49; Article Influence Score:3.851; JIF Percentile:98.4; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:54; % of Articles in Citable items:0.037; Cited Half-Life:8.2; Citing Half-Life:3.6; % of OA Gold:0.4059; Publisher name:BMC; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 SCIE期刊JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 2024/2025影响因子:1.449 (J INT MED RES) (0300-0605). (PHARMACOLOGY & PHARMA  ...234
Total Citations:10135; 2023 JIF:1.449; JIFRank: 275/354 ; Rank-JIF: 275; Number-of-JIF:354; 5 Year JIF:1.854; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.4; Immediacy Index:0.2; Immediacy Index-dealt:0.241; 2023 JCI:0.33; JCI Rank: 288/354 ; Total Articles:346; JCI Quartile:Q4; JCI Percentile:18.79; Eigenfactor:0.014; Normalized Eigenfactor:2.969; Article Influence Score:0.422; JIF Percentile:22.5; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:458; % of Articles in Citable items:0.7555; Cited Half-Life:4.3; Citing Half-Life:7.4; % of OA Gold:0.9119; Publisher name:FUNDACAO ZOOBOTANICA RIO GRANDE SUL, MUSEU CIENCIAS NATURAIS; Publisher
投票 SCIE期刊Expert Review of Clinical Pharmacology 2024/2025影响因子:3.643 (EXPERT REV CLIN PHAR) (1751-2433). (PHARMACOLOGY & PH  ...234
Total Citations:3312; 2023 JIF:3.643; JIFRank: 94/354 ; Rank-JIF: 94; Number-of-JIF:354; 5 Year JIF:4.138; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.5; Immediacy Index:0.6; Immediacy Index-dealt:0.627; 2023 JCI:0.7; JCI Rank: 163/354 ; Total Articles:35; JCI Quartile:Q2; JCI Percentile:54.1; Eigenfactor:0.005; Normalized Eigenfactor:1.028; Article Influence Score:1.102; JIF Percentile:73.6; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:98; % of Articles in Citable items:0.3571; Cited Half-Life:4.7; Citing Half-Life:5.8; % of OA Gold:0.1124; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 SCIE期刊EXPERT OPINION ON INVESTIGATIONAL DRUGS 2024/2025影响因子:4.942 (EXPERT OPIN INV DRUG) (1354-3784). (PHARMACOLOGY & P  ...234
Total Citations:5738; 2023 JIF:4.942; JIFRank: 45/354 ; Rank-JIF: 45; Number-of-JIF:354; 5 Year JIF:5.354; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.9; Immediacy Index:1; Immediacy Index-dealt:1.123; 2023 JCI:1.03; JCI Rank: 78/354 ; Total Articles:37; JCI Quartile:Q1; JCI Percentile:78.11; Eigenfactor:0.005; Normalized Eigenfactor:1.082; Article Influence Score:1.373; JIF Percentile:87.4; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:100; % of Articles in Citable items:0.37; Cited Half-Life:7.5; Citing Half-Life:5.5; % of OA Gold:0.1127; Publisher name:SOC ED IL MULINO; Publisher address:STRADA MAGGIORE 37, BOLOGNA, ITALY, 40125;
投票 SCIE期刊ARCHIVES OF PHARMACAL RESEARCH 2024/2025影响因子:6.948 (ARCH PHARM RES) (0253-6269). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:8491; 2023 JIF:6.948; JIFRank: 15/354 ; Rank-JIF: 15; Number-of-JIF:354; 5 Year JIF:5.753; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6.4; Immediacy Index:1.8; Immediacy Index-dealt:1.895; 2023 JCI:1.27; JCI Rank: 46/354 ; Total Articles:33; JCI Quartile:Q1; JCI Percentile:87.15; Eigenfactor:0.004; Normalized Eigenfactor:0.779; Article Influence Score:1.02; JIF Percentile:95.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:56; % of Articles in Citable items:0.5893; Cited Half-Life:10; Citing Half-Life:5.9; % of OA Gold:0.0924; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United St
投票 SCIE期刊NEUROPHARMACOLOGY 2024/2025影响因子:4.678 (NEUROPHARMACOLOGY) (0028-3908). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science C  ...234
Total Citations:22857; 2023 JIF:4.678; JIFRank: 57/354 ; Rank-JIF: 57; Number-of-JIF:354; 5 Year JIF:4.585; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.4; Immediacy Index:1.1; Immediacy Index-dealt:1.171; 2023 JCI:1.19; JCI Rank: 57/354 ; Total Articles:230; JCI Quartile:Q1; JCI Percentile:84.04; Eigenfactor:0.019; Normalized Eigenfactor:4.189; Article Influence Score:1.212; JIF Percentile:84; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:230; % of Articles in Citable items:1; Cited Half-Life:7.6; Citing Half-Life:9; % of OA Gold:0.3531; Publisher name:BMJ PUBLISHING GROUP; Publisher address:BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, L
投票 SCIE期刊BRITISH JOURNAL OF PHARMACOLOGY 2024/2025影响因子:6.863 (BRIT J PHARMACOL) (0007-1188). (PHARMACOLOGY & PHARMACY)(药理学  ...234
Total Citations:36780; 2023 JIF:6.863; JIFRank: 18/354 ; Rank-JIF: 18; Number-of-JIF:354; 5 Year JIF:7.481; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.7; Immediacy Index:1; Immediacy Index-dealt:1.144; 2023 JCI:1.71; JCI Rank: 19/354 ; Total Articles:155; JCI Quartile:Q1; JCI Percentile:94.77; Eigenfactor:0.022; Normalized Eigenfactor:4.763; Article Influence Score:1.682; JIF Percentile:95.1; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:222; % of Articles in Citable items:0.6982; Cited Half-Life:9.8; Citing Half-Life:7; % of OA Gold:0.4488; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MI
投票 SCIE期刊JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:1.517 (J VET PHARMACOL THER) (0140-7783). (PHAR  ...234
Total Citations:2670; 2023 JIF:1.517; JIFRank: 265/354 ; Rank-JIF: 265; Number-of-JIF:354; 5 Year JIF:1.557; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.4; Immediacy Index:0.4; Immediacy Index-dealt:0.412; 2023 JCI:0.55; JCI Rank: 218/354 ; Total Articles:50; JCI Quartile:Q3; JCI Percentile:43.15; Eigenfactor:0.001; Normalized Eigenfactor:0.238; Article Influence Score:0.299; JIF Percentile:60.8; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:52; % of Articles in Citable items:0.9615; Cited Half-Life:12.4; Citing Half-Life:11.4; % of OA Gold:0.1958; Publisher name:OXFORD UNIV PRESS; Publisher address:GREAT CLARENDON ST, OXFORD, ENGLAND,
投票 SCIE期刊JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES 2024/2025影响因子:2.982 (J PHARM PHARM SCI) (NULL). (PHARMACOLOGY & P  ...234
Total Citations:2319; 2023 JIF:2.982; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:2.602; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.9; Immediacy Index:0.8; Immediacy Index-dealt:0.889; 2023 JCI:0.84; JCI Rank: 116/354 ; Total Articles:15; JCI Quartile:Q2; JCI Percentile:67.37; Eigenfactor:0.001; Normalized Eigenfactor:0.221; Article Influence Score:0.512; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:19; % of Articles in Citable items:0.7895; Cited Half-Life:10.6; Citing Half-Life:6.5; % of OA Gold:0.9394; Publisher name:SAGE PUBLICATIONS LTD; Publisher address:1 OLIVERS YARD, 55 CITY ROAD, LON
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 13:55
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块